Target intelligence / Profile preview

Elongin C pseudogene 31 (ELOCP31)

Target
ELOCP31
Molecular classification
Other (specifically, pseudogene)
01

Overview

Elongin C pseudogene 31 (ELOCP31) is a human pseudogene located on Chromosome 12. Pseudogenes such as ELOCP31 are genomic sequences similar to known protein-coding genes—in this case, the elongin C (ELOC) gene—but have accumulated mutations that typically prevent them from producing functional proteins. ELOCP31 is not transcribed or translated into a functional elongin C protein, and there is no evidence linking this pseudogene to therapeutic, biological, or disease-related functions in humans. The true protein-coding version, elongin C (ELOC), functions as a regulatory subunit in the transcription factor B (SIII) complex and has important roles in transcription and ubiquitination complexes, but none of these functions apply to the ELOCP31 pseudogene.

Other names
TCEB1P31Transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) pseudogeneTranscription elongation factor B (SIII), polypeptide 1 pseudogene 31Transcription elongation factor B subunit 1 pseudogene 31ELOCP31
02

Mechanism of action

None (as above, pseudogenes are not targeted by drugs with a clear mechanism of action)

03

Biological functions

None (as a pseudogene, ELOCP31 does not produce a functional protein or carry out a known biological function)
04

Disease associations

None (no disease mechanisms known to involve this pseudogene)
05

Safety considerations

None (there are no safety concerns or therapeutic challenges associated with this pseudogene)
06

Interacting drugs

None (not a druggable target; no drugs target this pseudogene)
07

Biomarkers

None (ELOCP31 is not recognized as a biomarker for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on Elongin C pseudogene 31 (ELOCP31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 31 (ELOCP31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call